Search Results

Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study

• Authors : Pett, SL; Amin, J ; https://orcid.org/0000-0003-2161-9366

Subjects: 32 Biomedical and Clinical Sciences; 3202 Clinical Sciences; Sexually Transmitted Infections

• Source: urn:ISSN:1464-2662; urn:ISSN:1468-1293; HIV Medicine, 19, 1, 65-71

Record details

Chemokine receptor CCR5 correlates with functional CD8 + T cells in SIV‐infected macaques and the potential effects of maraviroc on T‐cell activation

• Authors : Kasi E. Russell-Lodrigue; Xiaolei Wang; Huanbin Xu

Subjects: 0301 basic medicine; Chemokine receptor CCR5; viruses

• Source: The FASEB Journal. 33:8905-8912

Record details

Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study.

• Authors : Pett SL; MARCH study group

Subjects: Drug Substitution*; Antiretroviral Therapy, Highly Active/Antiretroviral Therapy, Highly Active/Antiretroviral Therapy, Highly Active/*methods ; CCR5 Receptor Antagonists/CCR5 Receptor Antagonists/CCR5 Receptor Antagonists/*administration & dosage

• Source: HIV medicine [HIV Med] 2018 Jan; Vol. 19 (1), pp. 65-71. Date of Electronic Publication: 2017 Jul 13.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium:

Record details

Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.

• Authors : Poveda E; Hernández-Quero J ...

Subjects: Genotype* ; Viral Tropism*; DNA, Viral/DNA, Viral/DNA, Viral/*genetics

• Source: HIV medicine [HIV Med] 2017 Aug; Vol. 18 (7), pp. 482-489. Date of Electronic Publication: 2016 Dec 30.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium:

Record details

The CC Chemokine Receptor 5 (CCR5) antagonist Maraviroc inhibits drug‐choice in Sprague Dawley rats

• Authors : Briana Mason; Robert Seaman; Gregory Collins

Subjects: business.industry; medicine.drug_class; CCR5 receptor antagonist

• Source: The FASEB Journal. 35

Record details

Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study

• Authors : Pett, S. L.; Amin, J.; Horban, A.

Subjects: ddc:no; doc-type:article; publishedVersion

Record details

Role of Maraviroc in minimizing the risk of graft rejection in HIV‐infected kidney transplant recipients

• Authors : Gianni Cappelli; Erica Franceschini; Cristina Mussini

Subjects: Adult; Graft Rejection; Male

• Source: Transplant Infectious Disease. 22

Record details

Off-licence use of once-daily maraviroc in children and adolescents with perinatally acquired HIV-1 infection.

• Authors : Fraser-Taliente T; Visiting Nuffield Scholar, London, W2 1NY.; Mackie NE

Subjects: Off-Label Use*; CCR5 Receptor Antagonists/CCR5 Receptor Antagonists/CCR5 Receptor Antagonists/*administration & dosage ; Cyclohexanes/Cyclohexanes/Cyclohexanes/*administration & dosage

• Source: HIV medicine [HIV Med] 2017 Apr; Vol. 18 (4), pp. 311-313. Date of Electronic Publication: 2016 Dec 16.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium:

Record details

T005 (0077) TRABECTEDIN INHIBITS CLASSICAL HODGKIN LYMPHOMA GROWTH, MONOCYTES IMMUNOSUPPRESSIVE POLARIZATION BY TUMOR CELLS AND SYNERGIZES WITH THE CCR5-ANTAGONIST MARAVIROC

Subjects: Diseases of the blood and blood-forming organs; RC633-647.5

• Source: HemaSphere, Vol 2, Pp 1-2 (2018)

Record details

Maraviroc-Mediated Lung Protection following Trauma-Hemorrhagic Shock.

• Authors : Liu FC; Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan; College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.

Subjects: Cyclohexanes/Cyclohexanes/Cyclohexanes/*pharmacology ; Lung Injury/Lung Injury/Lung Injury/*prevention & control ; Shock, Hemorrhagic/Shock, Hemorrhagic/Shock, Hemorrhagic/*drug therapy

• Source: BioMed research international [Biomed Res Int] 2016; Vol. 2016, pp. 5302069. Date of Electronic Publication: 2016 Jul 31.Publisher: Wiley Country of Publication: United States NLM ID: 101600173 Publication Model: Print-Electronic Cited Medium:

Record details